عربي
English
Quick links
Related sites
Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Login area | Sign up
Forgot your password? Click here
Let us help you
Read about the latest topics.
Download the new version of the MOPH app 
for the latest updates on Coronavirus
 
Be Responsible
#Raise your voice
Send us any Fraudulent Action or Enquiry so we can ALL contribute to make a Difference

Lebanon National Drugs Database

This section represents the official information about the pharmaceutical products registered & marketed at the Ministry of Public Health
 
You can search in the form below for information related to drugs including Subsidy percentage

​Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022
 
    1
    ...
    61
    62
    63
    64
    65
    66
    ...
    187
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
All
ATC Name B/G Ingredients Dosage Form Price
L04AA32 1 G " Apremil 4x20mg L.L
L04AA32 1 B A 751 325" 19.35 D 1141 Amgen Europe BV The Netherlands 3/10/2025 L.L
L04AA31 1 G T 076 914" 10.71 E1 3/10/2025 L.L
L04AA31 1 G T 451 224" 10.71 E1 3/10/2025 L.L
L04AA31 1 B T 773 533" 19.35 D 347 Sanofi Winthrop Industrie France 3/10/2025 L.L
L04AA31 1 B T 773 533" 19.35 D 1304 Sanofi Aventis Groupe France 3/10/2025 L.L
L04AA29 4 G T 793 962" 2.44 E2 18 Hikma Pharmaceuticals Jordan 3/10/2025 L.L
L04AA29 2 B T 687 316" 10.71 E1 2783 Pfizer Europe MA EEIG Belgium 3/10/2025 L.L
L04AA29 1 G T 863 315" 10.71 E1 18 Hikma Pharmaceuticals Jordan 3/10/2025 L.L
L04AA29 1 G T 411 736" 10.71 E1 1695 Laboratorios Bago SA Argentine 3/10/2025 L.L
L04AA29 1 B T 473" 10. L.L
L04AA27 1 G F 079 643" 10.71 E1 3/10/2025 L.L
L04AA27 1 G F 264 981" 10.71 E1 3/10/2025 L.L
L04AA27 1 G F 580" 2.4 L.L
L04AA27 1 G F 406 715" 19.35 D 3529 Zentiva Pharma UK Limited UK 3/10/2025 L.L
L04AA27 1 B F 693" 2.4 L.L
L04AA23 1 Bio 594" 2.4 L.L
L04AA18 5 B E 962" 19. L.L
L04AA18 4 B E 962" 19. L.L
L04AA13 2 G L 014 420" 23.08 B 1664 Delorbis Pharmaceuticals Ltd Cyprus 3/10/2025 L.L
L04AA13 2 B L 346 168" 23.08 B 599 Sanofi Aventis Deutschland GmbH Germany 3/10/2025 L.L
L04AA13 1 G L 527 949" 23.08 B 1664 Delorbis Pharmaceuticals Ltd Cyprus 3/10/2025 L.L
L04AA13 1 B L 230 779" 23.08 B 599 Sanofi Aventis Deutschland GmbH Germany 3/10/2025 L.L
L04AA10 1 G S 729 193" 19.35 D 3/10/2025 L.L
L04AA10 1 B S 489" 21. L.L
L04AA06 4 G M 643 157" 23.08 B 1222 The Arab Pharmaceutical Manufacturing PSC Jordan 3/10/2025 L.L
L04AA06 4 G M 087 969" 23.08 B 1118 Les Laboratoires Medis SA Tunisia 3/10/2025 L.L
L04AA06 4 G M 791 428" 23.08 B 3/10/2025 L.L
L04AA06 4 B M 575" 23. L.L
L04AA06 3 B M 575" 23. L.L
    1
    ...
    61
    62
    63
    64
    65
    66
    ...
    187
Sitemap
© Copyrights reserved to Ministry of Public Health 2025